Health
New Metastatic Cervical Cancer Treatments Give Hope – Targeted Oncology
Investigators treating patients with gynecologic malignancies are optimistic that multiple clinical trials exploring new second-line cervical cancer treatments…
Investigators treating patients with gynecologic malignancies are optimistic that multiple clinical trials exploring new second-line cervical cancer treatments will result in a much-anticipated breakthrough for the field, with improved response rates from these new strategies already generating excitement.
In an interview with Targeted Therapies in Oncology(TTO), R. Wendel Naumann, MD, discussed the phase 1/2 CheckMate 358 trial (NCT02488759) in which patients received the PD-1 inhibitor nivolumab…
Continue Reading
